NCT06324006View on ClinicalTrials.gov

A Phase 1 Trial of LIB-01 in Healthy Participants.

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 25, 2023

Primary Completion Date

April 23, 2024

Study Completion Date

May 29, 2024

Conditions
Erectile Dysfunction
Interventions
DRUG

LIB-01

LIB-01 oral suspension

OTHER

Placebo

Placebo oral suspension

Trial Locations (1)

75237

Clinical Trial Consultants, Uppsala

Sponsors

Lead Sponsor

Dicot AB
All Listed Sponsors
lead

Dicot AB

INDUSTRY

NCT06324006 - A Phase 1 Trial of LIB-01 in Healthy Participants. | Biotech Hunter | Biotech Hunter